Technologies / DoubleClick Floodlight
DoubleClick Floodlight
1,497 companies recorded in DoubleClick Floodlight, page 9 of 15.
| Company | Country | Stage | Raised |
|---|---|---|---|
| Marr Labs | US | seed | $1.0M |
| MARTINEAU & ASSOCIATES | US | unknown | $2.0M |
| MarvelX | NL | seed | $5.8M |
| Marvix AI, Inc. | US | unknown | $2.8M |
| MATERIALS SCIENCES LLC | US | unknown | $1.9M |
| MATREGENIX INC | US | unknown | $1.8M |
| Matter Intelligence Inc. | US | unknown | $35.9M |
| MAVERICK CORPORATION | US | unknown | $1.8M |
| May Ventures | FR | series-b+ | $32.4M |
| Maze | GB | series-a | $27.0M |
| Mbryonics | IE | unknown | $2.7M |
| Meadow Memorials | US | series-a | $9.0M |
| Mechanical Orchard, Inc. | US | unknown | $69.2M |
| MEGA | DK | pre-seed | $1.8M |
| Melder | US | seed | $1.0M |
| Mem0 | US | series-a | $24.0M |
| Mendaera | US | series-b+ | $73.0M |
| Mente Systems Inc. | US | unknown | $2.5M |
| MENTIS SCIENCES INC | US | unknown | $1.8M |
| Menza | US | seed | $1.0M |
| Mercura | US | seed | $1.0M |
| Merida Biosciences | US | series-a | $121.0M |
| Merlin Labs | US | unknown | $2.0M |
| MESA PHOTONICS LLC | US | unknown | $1.6M |
| Mesh | US | series-b+ | $120.0M |
| MetaCTF, Inc. | US | unknown | $1.0M |
| MetisMotion | DE | unknown | $2.7M |
| Metreecs | FR | unknown | $2.7M |
| Metriport | US | series-a | $5.0M |
| MiAI Law | unknown | seed | $1.3M |
| MICROCURES INC | US | unknown | $1.4M |
| Microgen LLC | US | unknown | $3.0M |
| Midship | US | seed | $1.0M |
| Mifundo | EE | seed | $10.8M |
| Mile Two LLC | US | unknown | $1.8M |
| Miniswap | US | seed | $1.0M |
| MIRECULE INC | US | unknown | $2.4M |
| Mirror Security | IE | unknown | $4.6M |
| MirrorWeb | GB | series-b+ | $63.0M |
| Mobot | US | series-a | $5.0M |
| Mocha | US | seed | $1.0M |
| Modalai Inc | US | unknown | $2.0M |
| Modular | US | series-b+ | $250.0M |
| Modus | US | seed | $1.0M |
| MODUS OPERANDI, INC. | US | unknown | $1.9M |
| Molecular Express, INC | US | series-b+ | $2.0M |
| Momentic | unknown | unknown | $15.0M |
| Monda | DE | seed | $5.0M |
| Monk | US | series-a | $25.0M |
| Monnai | US | seed | $23.0M |
| Monte | US | seed | $1.0M |
| Moonset Health | US | seed | $1.0M |
| Moonwalk Biosciences | US | series-a | $57.0M |
| Morada.ai | unknown | unknown | $1.0M |
| Moreta | US | seed | $1.0M |
| MORSECORP, INC | US | unknown | $2.0M |
| Mosaic | US | seed | $1.0M |
| Mosanna Therapeutics | CH | series-a | $80.0M |
| Mosyle | US | unknown | $100.0M |
| Mote Hydrogen | US | series-a | $7.0M |
| Motive | US | series-b+ | $717.0M |
| Motives | GB | seed | $1.0M |
| Move AI | GB | seed | $17.5M |
| MOVIUS INTERACTIVE CORPORATION | US | unknown | $1.9M |
| MuchBetter (AI) | FR | seed | $4.3M |
| Multi4 Medical | SE | unknown | $2.7M |
| Multi4 Medical | SE | unknown | $2.7M |
| Multiplier Holdings | US | series-a | $27.5M |
| MUON SPACE INC | US | unknown | $3.0M |
| MYRIAD SENSORS, INC. | US | unknown | $1.7M |
| N-Fix | BE | unknown | $2.7M |
| Nabis | US | series-a | $5.0M |
| NanoCo | US | seed | $12.0M |
| Nanograb | US | seed | $1.0M |
| NANOMETICS LLC | US | unknown | $2.0M |
| Nanopower | NO | unknown | $2.7M |
| Nanopower Semiconductor | NO | series-a | $9.4M |
| Nanordica Medical | EE | seed | $1.9M |
| NanoXplore | FR | series-b+ | $21.6M |
| Naq | NL | series-a | $12.7M |
| NASONI, LLC | US | unknown | $2.5M |
| NATRION INC | US | unknown | $1.2M |
| Navier AI | US | seed | $1.0M |
| NCX CORPORATION | US | unknown | $1.2M |
| Ndea | US | seed | $1.0M |
| Nearfield Instruments | NL | unknown | $2.7M |
| Nectar Social | US | series-a | $30.0M |
| NeoCognition | US | seed | $40.0M |
| neoncoral | US | seed | $1.0M |
| NetFabric | CH | pre-seed | $2.2M |
| Netic | US | seed | $1.0M |
| Netomi | US | series-b+ | $200.0M |
| Netradyne | US | series-b+ | $90.0M |
| Neural Concept | CH | series-b+ | $100.0M |
| Neuralink | US | series-b+ | $680.0M |
| NEUREXIS THERAPEUTICS, INC. | US | unknown | $2.8M |
| Neuron23 | US | series-b+ | $310.0M |
| Neurophos | US | series-a | $118.0M |
| Neuros Medical | US | series-b+ | $56.0M |
| Neurovalens | GB | series-a | $21.6M |